Baszucki Brain Research Fund Backs First Clinical Pilot Trials of Ketogenic Metabolic Interventions for Mental Health Conditions in Nearly 60 Years

Attendees at the Inaugural Metabolic Psychiatry Meeting in 2022

July 18, 2022

The Baszucki Brain Research Fund is pleased to announce that five science teams around the globe have received funding to study ketogenic metabolic interventions for bipolar disorder, schizophrenia and major depressive disorder.

The Fund is providing $2 million in grants to support neurometabolic research focused on the benefits of carbohydrate-restricted ketogenic diet therapies for improving mental health outcomes. Building on preliminary research, including a recent retrospective analysis of thirty-one inpatients in France, the funding for the five research grants supports the first pilot trials of ketogenic interventions for mental illness since a single promising study in schizophrenia in 1965.